PLA2G2D and obesity disorder: In obesity and associated diseases, such as diabetes and cardiovascular disease, high plasma and tissue activities of secreted phospholipase A2 (sPLA2) enzymes, especially group IIA (GIIA) sPLA2s, have been demonstrated [1,2].